Mr. Thomas R. Malley is Independent Director at Puma Biotechnology, Inc., President at Mossrock Capital LLC, and Independent Director at Synageva BioPharma Corp.
He is on the Board of Directors at Puma Biotechnology, Inc. and Synageva BioPharma Corp.
Prior to joining Mossrock Capital LLC in May 2007, Mr. Malley was previously employed as Executive Vice President by Janus Capital Management LLC.
He also served on the board at Cougar Biotechnology, Inc., Cougar Biotechnology, Inc., Synageva BioPharma Corp., and Innovative Acquisitions Corp.
Mr. Malley received his BA in Biology from Stanford University.